HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 72 filers reported holding HARVARD BIOSCIENCE INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,795 | -42.4% | 3,788 | -14.3% | 0.00% | – |
Q1 2024 | $18,741 | -20.7% | 4,420 | 0.0% | 0.00% | – |
Q4 2023 | $23,647 | +37.0% | 4,420 | +10.1% | 0.00% | – |
Q3 2023 | $17,265 | -33.5% | 4,015 | -15.1% | 0.00% | – |
Q2 2023 | $25,963 | +8.2% | 4,729 | +22.8% | 0.00% | – |
Q1 2022 | $24,000 | -11.1% | 3,851 | 0.0% | 0.00% | – |
Q4 2021 | $27,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
Q3 2021 | $27,000 | -15.6% | 3,851 | 0.0% | 0.00% | – |
Q2 2021 | $32,000 | +77.8% | 3,851 | +15.6% | 0.00% | – |
Q1 2021 | $18,000 | +28.6% | 3,330 | 0.0% | 0.00% | – |
Q4 2020 | $14,000 | +40.0% | 3,330 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | -33.3% | 3,330 | -30.4% | 0.00% | – |
Q2 2020 | $15,000 | +50.0% | 4,782 | -8.5% | 0.00% | – |
Q2 2019 | $10,000 | -56.5% | 5,226 | 0.0% | 0.00% | – |
Q1 2019 | $23,000 | +35.3% | 5,226 | 0.0% | 0.00% | – |
Q4 2018 | $17,000 | -37.0% | 5,226 | 0.0% | 0.00% | – |
Q3 2018 | $27,000 | -3.6% | 5,226 | 0.0% | 0.00% | – |
Q2 2018 | $28,000 | – | 5,226 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AMH Equity Ltd | 2,199,922 | $6,269,778 | 8.31% |
272 Capital LP | 1,535,820 | $4,377,087 | 2.19% |
Meros Investment Management, LP | 835,213 | $2,380,357 | 1.13% |
Harvey Partners, LLC | 2,557,500 | $7,288,875 | 0.88% |
Acuitas Investments, LLC | 407,343 | $1,160,928 | 0.62% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,772,339 | $7,901,166 | 0.46% |
BARD ASSOCIATES INC | 296,995 | $846,436 | 0.32% |
Riverwater Partners LLC | 105,977 | $302,034 | 0.22% |
Granahan Investment Management | 1,925,398 | $5,487,384 | 0.22% |
HEARTLAND ADVISORS INC | 1,200,000 | $3,420,000 | 0.19% |